STORY SUMMARY

FDA warns of rare vision-loss side effect from GLP-1 drugs

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.

This is a brief summary of reporting from CBS News U.S.. Read the original for the full article and context.

Read original reporting ↗

More from CBS News U.S. · Latest headlines